BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16157002)

  • 1. Good practice for publishing the results of clinical trials.
    Wager E
    J Br Menopause Soc; 2005 Sep; 11(3):109-11. PubMed ID: 16157002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science].
    Ludwig WD; Hildebrandt M; Schott G
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(3):149-54. PubMed ID: 19554889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. True, false, whatever.
    Schultz S
    US News World Rep; 2001 Sep; 131(10):72-3. PubMed ID: 11573469
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines and policies for medical writers in the biotech industry: an update on the controversy.
    Foote M
    Biotechnol Annu Rev; 2004; 10():259-64. PubMed ID: 15504710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good publication practice for pharmaceutical companies.
    Wager E; Field EA; Grossman L
    Curr Med Res Opin; 2003; 19(3):149-54. PubMed ID: 12814125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Good Publication Practice for Pharmaceutical Companies": where are we now?
    Wager E
    MedGenMed; 2005 Apr; 7(2):6. PubMed ID: 16369385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good publication practice guidelines for medical communications agencies: a MedComm perspective.
    Bareket-Samish A; Denny M; Ruzicka B; Bogush M; Flynn K; Glinka K; McMahon-Wise B; Schiller S; Sjostedt P; Matheson N
    Curr Med Res Opin; 2009 Feb; 25(2):453-61. PubMed ID: 19192990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research results should be freely accessible!-- Case reports demonstrate obstacles to contact with drug industry].
    Eliasson M; Bergqvist D
    Lakartidningen; 2001 Sep; 98(37):3913-6. PubMed ID: 11586830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Authors' Submission Toolkit: a practical guide to getting your research published.
    Chipperfield L; Citrome L; Clark J; David FS; Enck R; Evangelista M; Gonzalez J; Groves T; Magrann J; Mansi B; Miller C; Mooney LA; Murphy A; Shelton J; Walson PD; Weigel A
    Curr Med Res Opin; 2010 Aug; 26(8):1967-82. PubMed ID: 20569069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good publication practice guideline for pharmaceutical companies.
    Wager E; Tumas JA; Field EA; Glazer NB; Schulz G; Grossman L
    Can J Gastroenterol; 2000 Oct; 14(9):749. PubMed ID: 11203252
    [No Abstract]   [Full Text] [Related]  

  • 11. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
    Legler UF
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 14. [The roles and responsibilities of the pharmaceutical industry].
    Dejgaard A; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An editor's considerations in publishing industry-sponsored studies.
    Droller MJ
    Urol Oncol; 2015 Mar; 33(3):149-54. PubMed ID: 25575712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industry-corrupted psychiatric trials.
    Amsterdam JD; McHenry LB; Jureidini JN
    Psychiatr Pol; 2017 Dec; 51(6):993-1008. PubMed ID: 29432499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications.
    Marušić A; Hren D; Mansi B; Lineberry N; Bhattacharya A; Garrity M; Clark J; Gesell T; Glasser S; Gonzalez J; Hustad C; Lannon MM; Mooney LA; Peña T
    BMC Med; 2014 Oct; 12():197. PubMed ID: 25604352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest in drug development: the practices of Merck & Co., Inc.
    Hirsch LJ
    Sci Eng Ethics; 2002 Jul; 8(3):429-42. PubMed ID: 12353373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Registering clinical trials in India.
    Bhatt A; Sewlikar S
    Natl Med J India; 2006; 19(1):1-3. PubMed ID: 16570676
    [No Abstract]   [Full Text] [Related]  

  • 20. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.